These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2025256)
1. A 16 amino-acid synthetic peptide, derived from human C3d, carries regulatory activity on in vitro phosphorylation of a cellular component of the human B lymphoma cells, Raji. Lyamani F; Gauffre A; Barel M; Fiandino-Tirel A; Hermann J; Frade R Biochem Biophys Res Commun; 1991 Mar; 175(3):823-30. PubMed ID: 2025256 [TBL] [Abstract][Full Text] [Related]
2. A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2-positive human lymphocytes and of normal resting B lymphocytes. Frade R; Hermann J; Barel M Biochem Biophys Res Commun; 1992 Oct; 188(2):833-42. PubMed ID: 1445326 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways. Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142 [TBL] [Abstract][Full Text] [Related]
4. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276 [TBL] [Abstract][Full Text] [Related]
5. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. Davis AE; Harrison RA; Lachmann PJ J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952 [TBL] [Abstract][Full Text] [Related]
6. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472 [TBL] [Abstract][Full Text] [Related]
7. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. Servis C; Lambris JD J Immunol; 1989 Apr; 142(7):2207-12. PubMed ID: 2784456 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345 [TBL] [Abstract][Full Text] [Related]
9. The generation of active fragments of complement receptor type 2 by trypsin digestion. Micklem K; Sim E; Sim RB FEBS Lett; 1985 Sep; 189(2):195-201. PubMed ID: 3876241 [TBL] [Abstract][Full Text] [Related]
10. Amino acid sequence of the trypsin-generated C3d fragment from human complement factor C3. Hellman U; Eggertsen G; Engström A; Sjöquist J Biochem J; 1985 Sep; 230(2):353-61. PubMed ID: 3876831 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies. Barel M; Fiandino A; Lyamani F; Frade R Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614 [TBL] [Abstract][Full Text] [Related]
12. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface. Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318 [TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. Sarrias MR; Franchini S; Canziani G; Argyropoulos E; Moore WT; Sahu A; Lambris JD J Immunol; 2001 Aug; 167(3):1490-9. PubMed ID: 11466369 [TBL] [Abstract][Full Text] [Related]
14. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Weis JJ; Tedder TF; Fearon DT Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668 [TBL] [Abstract][Full Text] [Related]
15. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. Meuth JL; Morgan EL; DiSipio RG; Hugli TE J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172 [TBL] [Abstract][Full Text] [Related]
16. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. Theofilopoulos AN; Dixon FJ; Bokisch VA J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225 [TBL] [Abstract][Full Text] [Related]
17. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d. Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205 [TBL] [Abstract][Full Text] [Related]
18. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789 [TBL] [Abstract][Full Text] [Related]
19. A minimum CR2 binding domain of C3d enhances immunity following vaccination. Bower JF; Ross TM Adv Exp Med Biol; 2006; 586():249-64. PubMed ID: 16893077 [TBL] [Abstract][Full Text] [Related]
20. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]